Background: New aryl substituted cyclohepta[b]pyridine and cyclohepta[d]pyrimidine derivatives
were synthesized. The sugar hydrazones of the synthesized pyridine and pyrimidine compounds
were also prepared.
Method: In addition, the 1,3,4-oxadiazolyl acyclic C-nucleoside analogs of the pyridine system were
prepared. The hemolytic, prebiotic, anticancer and antimicrobial activities of some of the synthesized
compounds were also studied. Compounds 10 and 12 showed high activity against MCF-7, HEPG-2
and HCT-116 cell lines with IC50 at range 3.56-8.55 μg/mL. In addition, the synthesized condensed
thiopyrimidine derivative 10 exhibited more potent bactericidal activity while compound 7 demonstrated
potent antifungal activity against Aspergillus niger. Furthermore, the synthetic compounds of
the pyrimidine base promoted the growth of lactic acid bacteria.
Results: The predicted binding patterns of three of the prepared derivatives as possible antagonists
against ERα were investigated which showed good binding patterns.
Keywords: Cyclohepta[d]pyrimidine, 1, 3, 4-Oxadiazolyl acyclic C-nucleoside, Haemolytic, Prebiotic, Anticancer, Antimicrobial.
Rights & PermissionsPrintExport